Topics

The precision medicine approach to cancer therapy: part 1 — solid tumours

10:44 EST 8 Nov 2019 | The Pharmaceutical Journal

An overview of the anticancer agents that have been approved for use in the UK as part of a precision medicine approach for solid tumours, along with information relating to the relevant biomarkers and biomarker assays currently available.

Original Article: The precision medicine approach to cancer therapy: part 1 — solid tumours

NEXT ARTICLE

More From BioPortfolio on "The precision medicine approach to cancer therapy: part 1 — solid tumours"

Quick Search

Relevant Topic

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...